AstraZeneca CFO on AI, Earnings, Restructuring Plan
THE SO WHAT
AstraZeneca’s CFO saying they use AI in “almost every aspect” of their work signals that, in pharma, AI is moving from pilot to fabric — across R&D, operations, and dealmaking. Healthcare and life sciences vendors that can’t plug into that AI-heavy workflow will find procurement doors closing faster.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIWikimedia Foundation Tries to Save Itself From Oblivion by Brokering AI Copyright Deal
If Wikimedia cuts a structured copyright deal with AI players, the reference layer of the internet starts to look more like a licensed data utility than a public commons. Content owners should be modeling upside from data licensing, not just downside from scraping.
Applied AIAnthropic's S1 | Google's AI Problem | The Rundown
Anthropic’s S-1 pulls frontier AI economics into public markets, while Google’s rough week underscores how hard it is to defend legacy profit pools during a platform shift. If you’re an enterprise buyer, expect pricing, bundling, and partnership terms to get more aggressive as these pressures surface in filings.
Applied AITheranos whistleblower Tyler Shultz warns that the AI boom is ‘a great opportunity to go deceive people’
When someone who lived through Theranos calls the AI boom a prime venue for deception, that’s a governance warning, not just a quote. Boards should be asking for hard evidence on model performance and economics, not just market comps and hype-driven valuations.
Applied AIPost-training 4B model with RL to fly Tesla Roadster 21% better than GPT-6 Astra
A 4B model post-trained with RL beating GPT‑6 Astra by 21% on a specific Roadster control task is another proof that narrow, tuned systems can outperform giants on well-scoped problems. For applied teams, budget should be shifting from chasing the biggest model to investing in task-specific training and feedback loops.